Song He
Overview
Explore the profile of Song He including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
391
Citations
2941
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yin H, Liao M, Shi Y, Liu Z, Li H, He S, et al.
Adv Mater
. 2025 Mar;
37(10):e2415957.
PMID: 40072021
The growth of large semiconductor crystals is crucial for advancing modern electronics and optoelectronics. While various crystal growth techniques have been developed for lead halide perovskites, a significant challenge remains:...
2.
Chen C, Bi Y, Chen B, He S
Gastroenterol Rep (Oxf)
. 2025 Mar;
13:goaf022.
PMID: 40066318
Background: Liver fibrosis is characterized by hepatic stellate cell (HSC) activation and collagen overproduction, but its pathogenesis remains largely unknown. This study aimed to uncover the role of neural precursor...
3.
Chen Z, He S, Chi X, Bo X
Int J Mol Sci
. 2025 Feb;
26(3).
PMID: 39941111
Antibodies are key proteins in the immune system that can reversibly and non-covalently bind specifically to their corresponding antigens, forming antigen-antibody complexes. They play a crucial role in recognizing foreign...
4.
Sui B, He Q, Yan B, Liu K, Xu Y, He S, et al.
iScience
. 2025 Feb;
28(2):111755.
PMID: 39906562
Hepatotoxicity prediction is significant in drug development, so the experts expect to get effective and reliable references. Based on the consideration that the hepatotoxicity data involve multiple types of features,...
5.
Bai C, Wu L, Li R, Cao Y, He S, Bo X
Adv Sci (Weinh)
. 2025 Feb;
:e2413405.
PMID: 39899688
Unexpected toxicity has become a significant obstacle to drug candidate development, accounting for 30% of drug discovery failures. Traditional toxicity assessment through animal testing is costly and time-consuming. Big data...
6.
Zhu S, Han M, Zong Y, Meng F, Liu Q, Tuo B, et al.
Clin Transl Gastroenterol
. 2025 Jan;
PMID: 39836012
Introduction: X842 is a new type of gastric acid-suppressing agent with a rapid onset of action and a long duration of effect. We aim to investigate the efficacy and safety...
7.
Li Z, He S, Xie L, Bai H, Cheng D, Zhang W, et al.
Zhongguo Zhen Jiu
. 2025 Jan;
45(1):21-6.
PMID: 39777873
Objective: To evaluate the clinical efficacy of ultrasound-guided needle knife release with different pathways for carpal tunnel syndrome (CTS). Methods: Sixty CTS patients were randomly divided into a transverse group...
8.
Su Q, Lu Y, He S, Liang J, Huang S, He Y, et al.
Sci Rep
. 2025 Jan;
15(1):210.
PMID: 39747981
Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), decreases quality of life and causes disability. The underlying processes are not fully understood. This study uses Mendelian...
9.
Wu T, Zhao L, Ren M, He S, Zhang L, Fang M, et al.
Environ Sci Technol
. 2025 Jan;
59(1):5-10.
PMID: 39745662
No abstract available.
10.
Lei J, Lv L, Zhong L, Xu F, Su W, Chen Y, et al.
Adv Sci (Weinh)
. 2024 Dec;
12(8):e2413128.
PMID: 39739648
Approximately 50% of the patients with ulcerative colitis (UC) are primarily nonresponsive to anti-tumor necrosis factor (TNF) therapy or lose their responsiveness over time. The gut microbiota plays an important...